These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 31626862

  • 21. Investigating the feasibility of temperature-controlled accelerated drug release testing for an intravaginal ring.
    Externbrink A, Clark MR, Friend DR, Klein S.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):966-73. PubMed ID: 23791685
    [Abstract] [Full Text] [Related]

  • 22. The ins and outs of drug-releasing vaginal rings: a literature review of expulsions and removals.
    Boyd P, Merkatz R, Variano B, Malcolm RK.
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1519-1540. PubMed ID: 32684013
    [Abstract] [Full Text] [Related]

  • 23. Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.
    McBride JW, Boyd P, Dias N, Cameron D, Offord RE, Hartley O, Kett VL, Malcolm RK.
    J Control Release; 2019 Mar 28; 298():1-11. PubMed ID: 30731150
    [Abstract] [Full Text] [Related]

  • 24. Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance.
    Murphy DJ, Lim D, Armstrong R, McCoy CF, Bashi YHD, Boyd P, Derrick T, Spence P, Devlin B, Malcolm RK.
    Drug Deliv Transl Res; 2023 Aug 28; 13(8):2072-2082. PubMed ID: 34674162
    [Abstract] [Full Text] [Related]

  • 25. Preparation and in vitro/in vivo evaluation of gestodene (GEST) intravaginal ring.
    Li C, Ning M, Yao X, Wang Y, Liu Y.
    Pak J Pharm Sci; 2016 Sep 28; 29(5):1545-1553. PubMed ID: 27731811
    [Abstract] [Full Text] [Related]

  • 26. 3D printing of vaginal rings with personalized shapes for controlled release of progesterone.
    Fu J, Yu X, Jin Y.
    Int J Pharm; 2018 Mar 25; 539(1-2):75-82. PubMed ID: 29366944
    [Abstract] [Full Text] [Related]

  • 27. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.
    Malcolm RK, Woolfson AD, Toner CF, Morrow RJ, McCullagh SD.
    J Antimicrob Chemother; 2005 Nov 25; 56(5):954-6. PubMed ID: 16155060
    [Abstract] [Full Text] [Related]

  • 28. Vaginal rings for menopausal symptom relief.
    Ballagh SA.
    Drugs Aging; 2004 Nov 25; 21(12):757-66. PubMed ID: 15382956
    [Abstract] [Full Text] [Related]

  • 29. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
    Eriksen B.
    Am J Obstet Gynecol; 1999 May 25; 180(5):1072-9. PubMed ID: 10329858
    [Abstract] [Full Text] [Related]

  • 30. The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
    Davies GC, Feng LX, Newton JR, Dieben TO, Coelingh-Bennink HJ.
    Contraception; 1992 May 25; 45(5):511-8. PubMed ID: 1623721
    [Abstract] [Full Text] [Related]

  • 31. Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles.
    Victor A, Johansson ED.
    Contraception; 1976 Aug 25; 14(2):215-26. PubMed ID: 949897
    [No Abstract] [Full Text] [Related]

  • 32. Estradiol-delivering vaginal rings for hormone replacement therapy.
    Nash HA, Alvarez-Sanchez F, Mishell DR, Fraser IS, Maruo T, Harmon TM.
    Am J Obstet Gynecol; 1999 Dec 25; 181(6):1400-6. PubMed ID: 10601920
    [Abstract] [Full Text] [Related]

  • 33. [Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel].
    Elkik F, Basdevant A, Corvol P.
    Arch Mal Coeur Vaiss; 1985 Oct 25; 78(11):1737-9. PubMed ID: 3938250
    [Abstract] [Full Text] [Related]

  • 34. Matrix Vaginal Rings for Female Dogs-Effect of Altering Dimensions on Mechanical Properties and Dissolution Characteristics, and In vivo Safety Study.
    Nováková Tkadlečková V, Pitronová V, Kubová K, Pavloková S, Elbl J, Novotný R, Vetchý D, Vysloužil J.
    AAPS PharmSciTech; 2020 Aug 10; 21(6):230. PubMed ID: 32779033
    [Abstract] [Full Text] [Related]

  • 35. In vitro release of nonoxynol-9 from silicone matrix intravaginal rings.
    Malcolm K, Woolfson D, Russell J, Andrews C.
    J Control Release; 2003 Sep 04; 91(3):355-64. PubMed ID: 12932713
    [Abstract] [Full Text] [Related]

  • 36. A dynamic mechanical method for determining the silicone elastomer solubility of drugs and pharmaceutical excipients in silicone intravaginal drug delivery rings.
    Malcolm RK, McCullagh S, Woolfson AD, Catney M, Tallon P.
    Biomaterials; 2002 Sep 04; 23(17):3589-94. PubMed ID: 12109683
    [Abstract] [Full Text] [Related]

  • 37. An oestrone-releasing vaginal ring in the treatment of climacteric women.
    Sipinen S, Lähteenmäki P, Luukkainen T.
    Maturitas; 1980 Dec 04; 2(4):291-9. PubMed ID: 7231201
    [Abstract] [Full Text] [Related]

  • 38. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
    Landgren BM, Johannisson E, Xing S, Aedo AR, Diczfalusy E.
    Contraception; 1985 Dec 04; 32(6):581-601. PubMed ID: 3937664
    [Abstract] [Full Text] [Related]

  • 39. New delivery systems in contraception: vaginal rings.
    Johansson ED, Sitruk-Ware R.
    Am J Obstet Gynecol; 2004 Apr 04; 190(4 Suppl):S54-9. PubMed ID: 15105799
    [Abstract] [Full Text] [Related]

  • 40. Dissolution testing of oral film preparations: Experimental comparison of compendial and non-compendial methods.
    Speer I, Preis M, Breitkreutz J.
    Int J Pharm; 2019 Apr 20; 561():124-134. PubMed ID: 30826424
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.